基于RNA的医学:从分子机制到疗法
Anke Sparmann1, Jörg Vogel1,2
1Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), Würzburg, Germany.
The EMBO journal
|September 20, 2023
概括
包括mRNA疫苗在内的RNA药物正在彻底改变疾病治疗. 本综述涵盖了各种RNA治疗策略及其临床机会和挑战,以罕见遗传疾病为例.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 基于RNA的疗法为治疗和预防人类疾病提供了变革性的潜力.
- 早期的研究挑战为重大进步铺平了道路,特别是COVID-19大流行期间mRNA疫苗的快速开发.
- RNA药物处于关键时刻,准备广泛临床应用.
研究的目的:
- 为各种基于RNA的治疗策略提供全面的概述.
- 检查与RNA药物的临床应用相关的机会和挑战.
- 用罕见遗传疾病作为案例研究来说明RNA疗法的潜在影响.
主要方法:
- 审查已建立和新兴的基于RNA的治疗方式.
- 对反意义和RNA干扰 (RNAi) 机制的分析.
- 探索基于信使RNA (mRNA) 的方法和CRISPR-Cas介导的基因组编辑.
主要成果:
- 确定了多种基于RNA的新疗法开发策略.
- 强调了RNA疗法的成功应用,以mRNA疫苗为例.
- 详细介绍了将RNA药物应用于罕见遗传疾病的具体机会和挑战.
结论:
- RNA药物代表一种具有广泛临床潜力的强大而多用途的治疗类.
- 克服现有的挑战对于广泛采用基于RNA的治疗方法至关重要.
- 进一步的研究和开发对于充分实现RNA治疗各种疾病的承诺至关重要.
相关概念视频
Microorganisms in Medicine and Therapeutics
53
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
53
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
Gene Therapy
25.5K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.5K


